News

September 14, 2020September 14, 2020

Cosentyx Effective in Active nr-axSpA, Phase 3 PREVENT Trial Shows

News

Treatment with Cosentyx (secukinumab) leads to sustained reductions in symptoms of active non-radiographic axial spondyloarthritis (nr-axSpA) over one year, according to the Phase 3 PREVENT trial. These findings were ... Read more

September 3, 2020September 3, 2020

Same But Different Photo Contest Celebrates People With Rare Diseases

News, syndicated

Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography competition to raise awareness for rare diseases. Under the theme ... Read more

August 31, 2020August 31, 2020

AbbVie Seeks FDA, EMA Approvals of Rinvoq for Active AS

News

AbbVie has submitted an application to the U.S. Food and Drug Administration (FDA) requesting the approval of Rinvoq (upadacitinib) for the treatment of adults with active ankylosing spondylitis (AS). ... Read more

August 25, 2020August 25, 2020

Xperiome Platform Aims to Streamline Searches for Rare Diseases, Gain Patient Input

News, syndicated

Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the search for new medicines for rare disorders and incorporating more patient ... Read more

August 24, 2020August 24, 2020

TNF Inhibitors Significantly Slow Bone Damage in AS, Long-term Study Finds

News

Disease progression slowed significantly in people with ankylosing spondylitis (AS) when they were on TNF inhibitors, compared to when they were off the medications, a long-term study has found. ... Read more

August 20, 2020August 20, 2020

EveryLife Foundation Launches Scholarship Fund for Rare Disease Community in US

News, syndicated

The EveryLife Foundation for Rare Diseases has launched a scholarship fund in the U.S. to support individuals with rare disorders who are pursuing personal goals through training and education. ... Read more

August 17, 2020August 17, 2020

IL-17 Inhibitors Can Ease Symptoms But Raise Infection Risk, Review Shows

News

Treatments blocking interleukin (IL)-17A, the so-called IL-17 inhibitors, can effectively ease symptoms in people with ankylosing spondylitis (AS), but also increase the risk of mild to moderate infections, a review ... Read more

August 12, 2020August 12, 2020

New Streaming Channel Showcases Rare Disease Films

News, syndicated

When the COVID-19 pandemic forced the postponement of a rare disease film festival originally slated for May, its organizers set out to find a new way to bring the ... Read more

August 10, 2020August 10, 2020

nr-axSpA Given Diagnostic Code on International Classification of Diseases

News

Non-radiographic axial spondyloarthritis (nr-axSpA) has been given a diagnostic code, M46.80, that will be used to identify the condition in the 10th edition of the International Classification of Diseases, ... Read more

August 3, 2020August 3, 2020

Year’s Use of Cimzia Can Lead to Sustained Remission, Phase 3b Trial Shows

News

Nearly one year of treatment with Cimzia (certolizumab pegol) led to sustained disease remission and a better quality of life in adults with early axial spondyloarthritis (axSpA), according to ... Read more

Pin It on Pinterest